stock price
Akero Therapeutics Stock Skyrockets as Phase 2b MASH Trial Yields Groundbreaking Results
Akero Therapeutics, MASH, Efruxifermin, Phase 2b SYMMETRY Study, Stock Price, Transformational Data
Xilio Therapeutics Stock Plunges Following Initial Phase 2 Data for Vilastobart in Colorectal Cancer Treatment
Xilio Therapeutics, Vilastobart, Anti-CTLA-4, Colorectal Cancer, Stock Price, Phase 2 Data